[email protected] Combating Tobacco Smoking Ann McNeill, PhD Honorary Senior Lecturer...

101
[email protected] Combating Tobacco Smoking Ann McNeill, PhD Honorary Senior Lecturer Independent consultant in public health
  • date post

    21-Dec-2015
  • Category

    Documents

  • view

    215
  • download

    1

Transcript of [email protected] Combating Tobacco Smoking Ann McNeill, PhD Honorary Senior Lecturer...

[email protected]

Combating Tobacco Smoking

Ann McNeill, PhD

Honorary Senior Lecturer

Independent consultant in public health

Sources:

• www.treatobacco.net

• www.ash.org.uk

A resource

Global smoking

• There are an estimated 1.1 billion smokers worldwide, representing about a third of the adult global population

• 800m in developing countries and most of these are men (700m)

• In China there are about 300m smokers

World cigarette production

0

1

2

3

4

5

6

1950 1960 1970 1980 1990 2000

Tri

llio

ns

Source: US Department of Agriculture

Who smokes?

Smoking since 1948

0

10

20

30

40

50

60

70

1948

1954

1960

1966

1972

1978

1984

1990

1996

Percentage

Men

Women

Smoking and deprivation

0 1 2 3 4 50

10

20

30

40

50

60

70

80

% p

reva

len

ce

UK CIGARETTE SMOKING BY DEPRIVATION

1973

1996

DEPRIVATION SCOREMost affluent Poorest

Jarvis (1997)

Figure 1: Smoking prevalence among pregnant women by social class1992-1999

14 1411

1411

1513

10

1513

3634

36 35

4139

37

32

43

37

27 26 27 26 27 2826

22

3027

0

5

10

15

20

25

30

35

40

45

50

Jan-92 Mar-92

Mar-93

Mar-94

Mar-95

Mar-96

Mar-97

Mar-98

Mar-99

All

ABC1

C2DE

All

UK Smoking Summary

• 28% men, 28% women smoked in 1996, decline in adults plateauing, possibly increasing again

• No changes in young peoples’ smoking

• No changes in pregnant womens’ smoking

• Large socioeconomic differences

Some impacts - Health

• Of those who smoke regularly, around one half will die prematurely

• Smoking caused 120,000 deaths in UK in 1995

• Smoking related diseases cost the NHS approx £1.5 billion a year in England

Some impacts - Health

• Cancer

• Heart & Circulation

• Respiratory

• 20 fatal illnesses

• 50 non-fatal illnesses

• Widespread addiction

Health Impacts - Passive Smoking

• Harm to others - – 600 cases of Lung cancer

– 12,000 cases of heart disease

– Trigger to 3.4 million asthma sufferers

– Pregnancy complications and cot death

– 17,000 hospital cases per year in under-5s

– 3 million non smokers work in smokey conditions

0 20 40 60 80 100

Lung Cancer

Emphysema

Stroke

Heart Disease

Heart Disease

All Cancers

Infant Deaths

Source: 1989 Surgeon General's Report. Data from USA.

(under 65)

(all ages)

87%

82%

18%

40%

21%

33%

10%

Cigarettes are among the leading causes of death in the United States

Sources: (AIDS) HIV/AIDS Surveillance Report, 1998; (Alcohol) McGinnis MJ, Foege WH. Review: Actual Causes of Death in the United States.JAMA 1993;270:2207-12; (Motor vehicle) National Highway Transportation Safety Administration, 1998; (Homicide, Suicide) NCHS, vital statistics, 1997; (Drug Induced) NCHS, vital statistics, 1996; (Smoking) SAMMEC, 1995

Annual Deaths from Smoking Compared with Selected Other Causes in the United States

17

8141

19 14 30

430

04080

120160200240280320360400440

Nu

mb

er

of

De

ath

s (

tho

us

an

ds

)

Why do people smoke?

• The tobacco industry

• Most smoke because they are addicted to nicotine (affects nearly every organ)

• Recent expert reports show that tobacco delivered nicotine is as addictive as heroin, cocaine etc

• Most smokers want to quit but cannot

Key Findings

• Tobacco dependence & withdrawal syndromes classified as substance use disorders under WHO ICD 10

• Nicotine dependence & withdrawal classified similarly under APA DSM IV

• More common general term is addiction

Rapid absorption of nicotine reinforces smoking behaviour

Why it is so hard to stop smoking

0

5

10

15

20

25

30

0 10 20 30 40 50 60

Cigarette

Time after smoking a cigarette (mins)Time after smoking a cigarette (mins)

Pla

sma

nic

oti

ne

(mg

/mL

)P

lasm

a n

ico

tin

e (m

g/m

L)

1. Royal College of Physicians, 2000.

The power of addiction

AllAllsmokerssmokers

~2–3%~2–3%succeed insucceed instoppingstopping

each yeareach year33

~~70%70%want to stopwant to stop11

~~30%30%try each yeartry each year22

Why it is so hard to stop smoking

1. Bridgwood et al., 2000.2. West, 1997.3. Arnsten, 1996.

Addiction

“The cigarette should be conceived not as a product but as a package. The product is nicotine.…Think of the cigarette pack as a storage container for a day’s supply of nicotine.…Think of a cigarette as a dispenser for a dose unit of nicotine. Think of a puff of smoke as the vehicle of nicotine.…

Smoke is beyond question the most optimised vehicle of nicotine and the cigarette the most optimised dispenser of smoke.”

• Philip Morris 1972

Reducing this public health burden

• Preventing young people taking up smoking (prevention)

• Encouraging smokers to stop (cessation)

• Harm reduction approaches

Age at which smokers start

16

73

11

0

10

20

30

40

50

60

70

80

Percentage of smokers

by age 12 13 to 17 after 18

US data 1991, Institute of Medicine

0

300

400

500

2025 205020001950

100

200

Year

70

190

220

340

500

520

Unless Current Smokers Quit, Tobacco Deaths will Rise Dramatically in the Next 50 yearsEstimated cumulative tobacco deaths 1950-2050 with different intervention strategies

To

bac

co d

eath

s (m

illio

ns)

— Baseline

— If proportion of young adults taking up smoking halves by 2020If adult consumption halves by 2020

World Bank. Curbing the epidemic: Governments and the economics of tobacco control. World Bank Publications, 1999. p80.

Interventions

• School health education

• Restricting sales to minors

• Advertising bans

• Price rises

• No smoking policies

• Media & community-wide campaigns

• Cessation interventions

• Product modification

Assessing interventions

• Efficacy

• Effectiveness

• Reach

• Cost-effectiveness

Smoking Kills: A White Paper on Tobacco

• To reduce smoking among children & young people

• To help adults, especially the most disadvantaged, to give up

• To offer particular help to pregnant women who smoke

• (Lack of harm reduction apps)

Targets

• To reduce smoking among children from 13% to 9% by 2010 (2005 -11%)

• To reduce adult smoking from 28% to 24% by 2010 (2005 - 26%)

• To reduce smoking among pregnant women from 23% to 15% by 2010 (2005 - 18%)

Prevention

• Why do young people smoke?– sociodemographic variables

– peer & sibling smoking

– parental smoking & support

– low academic achievement, alienation

– rebelliousness

– lack skills to resist offers, low self-esteem

Prevention

• Why do young people smoke?– Many young smokers are already

dependent on nicotine

– They want to stop, have tried and failed

– They inhale and take in substantial doses of nicotine from their cigs

– Experimenters highly likely to become regular daily smokers

Prevention

• Unanswered questions…– is there a minimum dosage of nicotine

necessary

– is daily use a prerequisite to dependence

– are there gender/ethnic differences

– are there genetic factors involved

Prevention

• School programmes– health hazards did not affect smoking

– social learning theory based programmes delay onset for 4-10 years

– when programmes implemented in real life they have been shown to be ineffective

– comprehensive programmes dealing with range of health issues may be > effective

Prevention

• Restricting sales to minors– laws rarely enforced - v expensive

– young people still easily buy tobacco

– evasion rife - ID card forgery, asking others to buy for them

– a few intensive campaigns have worked, but divert attention from tobacco industry to retailers/children & drugs field shows inadequacy of supply issues

Illegal sales recommendations

• Unpaid media to encourage retailers to comply with the law

• Work with magistrates to encourage higher fines

• Restrict retail outlets for tobacco?

• Fine the industry rather than retailers for illegal sales

Advertising bans

• Total ban on advertising, sponsorship, promotion is necessary

• Tobacco industry circumvent partial bans

• Some evidence that advertising bans reduce young people’s smoking

• Govt reported showed advertising bans reduce cigarette consumption

How it works - part 1

Younger adult smokers are the only source of replacement smokers... If younger adults turn away from smoking, the industry must decline, just as a population which does not give birth will eventually dwindle.

(RJ Reynolds, 1984)

How it works - part 2

A cigarette for the beginner is a symbolic act. I am no longer my mother's child, I'm tough, I am an adventurer, I'm not square …

As the force from the psychological symbolism subsides, the pharmacological effect takes over to sustain the habit.

(Philip Morris,1969)

Examples of Marketing

Examples of Marketing

Appeal to kids

Tobacco sponsorship

Advertising bans

• EU Directive adopted on 22 June 1998 struck down by European Court of Justice

• UK enacting own ban following a private members bill which is currently going through the Houses of Parliament

Taxation

• Price inversely related to consumption

• May have an influence on young people’s smoking

• UK has high tax policy

• Goal - balance this with real support for those wanting to quit - hypothecation?

Price of 20 cigarettes in 2000

£0.80 £2.72 £0.62

Price = £4.14

Taxes = £3.34

Affordability of cigarettes

EU tobacco taxation

£0.00

£0.50

£1.00

£1.50

£2.00

£2.50

£3.00

£3.50

Tax

per

20

ciga

rett

es

Smuggling

• Increased from 3% 96/97 to 22% 2000

• 80% containers, 20% white van

• Loss to revenue £3.8 bn

• £35m over three years to combat tobacco smuggling

• Extra customs officers

• Tougher penalites

Responses - Smuggling

• Treat Smuggling as a criminal activity

• Big Tobacco benefits from smuggling

• Canadian Government is suing RJ Reynolds

• The DTI is investigating BAT

No smoking policies

• Growing evidence of effectiveness of workplace bans

• Reduces passive smoking exposure

• Associated with increases in productivity

UK approach

• Voluntary action preferred over legislation

• Public places charter developed with the hospitality industry, problem pubs

• Approved Code of Practice (legal guidance for workplaces) stalled

• Opposition DTI & DCMS

Public places charter

The signatories to this Charter recognise that non-smoking is the general norm and that there should be increasing provision of facilities for non- smokers and the availability of clean air.

Workplaces with Smoking Policies (1995)

77%

71%

63%

62%

53%

48%

38%

36%

14%

Schools & Colleges

Hospitals and Clinics

Shops

Libraries Museums

Cinemas & Theatres

Banks & Post Offices

Travel

Restaurants &Cafes

Pubs

80% target

Source: NOP (1996) Smoking in public places: 2nd survey report

Approved Code of Practice

• ACoP is ‘quasi-legal’ like Highway Code

• Gives meaning to Health & Safety at Work Act

• Employers must take all reasonable and practicable steps to reduce or eliminate passive smoking exposure

• Presumption in favour of banning smoking

Mass media & community campaigns

• Effective in reducing adult smoking

• Model = combination of both

• Little effect with teenage smoking behaviour

• Expensive

• Unpaid publicity & media advocacy > cost-effective

Mass media & community campaigns

• £50m over 3 years for public education

• Priority groups - young people, adults who want to quit, pregnant women

• National media activity

• Local involvement

Health Benefits of Smoking Cessation

• Major & immediate health benefits for men and women of all ages whether or not they have smoking-related diseases

• Former smokers live longer than continuing smokers

• Decreases risk of lung & other cancers, heart attack, stroke, & COPD & can affect reproductive outcomes

Cessation interventions

• Not routine - in spite of supporting evidence

• Advice on smoking given to:– only 29% of smokers by GP (HEA, 1995)

– only 39% of pregnant smokers (HEA, 1996)

Smoking cessation guidelines

• Based on evidence from:– AHCPR Guidelines

– Cochrane Centre Reviews

• Evidence based evidence

• Peer-reviewed and professionally endorsed

Smoking cessation guidelines

• Raw M, McNeill A, West R. Smoking Cessation Guidelines for Health Professionals. Thorax, 1998; 53 (Suppl 5, Part 1): S1-S19

• West R, McNeill A, Raw M. Smoking cessation guidelines for health professionals: an update. Thorax, 2000; 55: 987-999.

Brief opportunistic advice

Intervention Targetpopulation

Effect size 95% CI

Briefopportunisticadvice from aphysician tostop

Smokersattending GPsurgeries oroutpatient clinics

2% 1-3%

Brief advice from a primary care physician during a routine consultation is effective in increasing the number of smokers stopping for at least 6 months

West R, McNeill A and Raw M. Thorax 2000; 55: 987-999. Silagy C. Physician advice for smoking cessation. Cochrane Database Syst Rev 2002; 1.

West R, McNeill A and Raw M. Thorax 2000; 55: 987-999.

Brief opportunistic advice

• May trigger quit attempt in 40% of cases

• Reduced effect with repeated exposure

• Minimal effect on heavy smokers in absence of NRT/bupropion or beh suppt

• GPs prefer to give to patients with smoking-related diseases but no greater in effect in this group

West R, McNeill A and Raw M. Thorax 2000; 55: 987-999. USDHHS. Treating Tobacco use and dependence. A clinical practice guideline. Rockville, MD AHQR 2000.Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev 2002; 1. Stead LF, Lancaster T. Group therapy for smoking cessation. Cochrane Database Syst Rev 2002; 1.

Face-to-face behaviouralsupport

• Behavioural support with multiple sessions of individual or group counselling aids smoking cessation,

• Dose-response relationship between the amount of therapist-client contact and successful cessation

Face-to-face behaviouralsupport

Intervention Targetpopulation

Effectsize

95% CI

Face-to-face intensivebehavioural support from aspecialist

Moderate toheavysmokersseeking helpwith stopping

7% 3%-10%

Face-to-face intensivebehavioural support from aspecialist

Smokersadmitted tohospital

4% 0%-8%

West R, McNeill A and Raw M. Thorax 2000; 55: 987-999.

USDHHS. Treating Tobacco use and dependence. A clinical practice guideline. Rockville, MD AHQR 2000.

Effect of smokers clinic

Intervention Population Effect

Intensivebehaviouralsupport plus NRTor bupropion

Moderate to heavy smokersseeking help from a smokersclinic

13-19%

West R, McNeill A and Raw M. Thorax 2000; 55: 987-999.

Expected effect combining effect of medication with effect of behavioural support

1. Rice VH, Stead LF. Cochrane Database Syst Rev 2002; 1. 2. West R, McNeill A and Raw M. Thorax 2000; 55: 987-999.

Face-to-face behaviouralsupport

• Nurses can be effective where trained and employed for the purpose1

• Specialist counselling for pregnant smokers is effective but brief midwife delivered advice probably is not2

• There has been limited research on support for adolescent smokers, and no clear evidence2

Self-help interventions

Intervention Target population Effectsize

95% CI

Written self-helpmaterials

Smokers seekinghelp with stopping

1% 0%-2%

Generic self-help interventions provided without personal support have a small effect on quit rates. Their impact is smaller and less certain than face-to-face interventions

Lancaster T, Stead LF. Self-help interventions for smoking cessation. Cochrane Database Syst Rev 2002; 1. West R, McNeill A and Raw M. Thorax 2000; 55: 987-999.

7.1 7.7

30.7

9

0

5

10

15

20

25

30

35

Light / moderate (<20 cig/day) Heavy (>20 cig/day)

Cigarettes smoked per day

Generic materialsTailored materials

Strecher VJ. Patient Educ Couns 1999; 36: 107-117.Strecher VJ, et al. Journal of Family Practice 1994; 39(3): 262–270.

% A

bst

inen

t at

4 m

on

ths

Tailored vs. generic behavioural support material

There is some evidence that self-help materials tailored for the needs of individual smokers are more effective than standard materials

Other support

Intervention Target population Effectsize

95% CI

Pro-activetelephonecounselling

Smokers wantinghelp with stoppingbut not receivingface to face support

2% 1%-4%

Telephone calls from a counsellor may be more effective than self-help materials alone

West R, McNeill A and Raw M. Thorax 2000; 55: 987-999.

USDHHS. Treating Tobacco use and dependence. A clinical practice guideline. Rockville, MD AHQR 2000.

Nicotine replacement therapy

• Nicotine replacement therapy (NRT) can be used instead of tobacco to aid quitting

• NRT delivers nicotine without toxins from tobacco

• NRT helps combat symptoms of withdrawal

• Nicotine dose from NRT is lower & administered more gradually than with smoking and this reduces the addictive potential

West R, McNeill A and Raw M. Thorax 2000; 55: 987-999. Silagy C, et al. Cochrane Database Syst Rev 2002; 1. USDHHS. Treating Tobacco use and dependence. A clinical practice guideline. Rockville, MD AHQR 2000.

Nicotine Replacement Therapy

• Effectiveness of NRT does not depend on the amount of face-to-face behavioural support

• All forms NRT appear to be similarly effective

• Choice may be based on susceptibility to side effects, patient preference and availability

• There is evidence that heavy smokers are more successful on 4mg than 2mg nicotine gum

West R, McNeill A and Raw M. Thorax 2000; 55: 987-999. Silagy C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2002; 1. USDHHS. Treating Tobacco use and dependence. A clinical practice guideline. Rockville, MD AHQR 2000.

Nicotine Replacement Therapy

• There has been little research on combinations of different types of NRT

• There is limited evidence that adding another form of NRT to the nicotine patch increases success rates

Minutes

Incr

ease

in

nic

oti

ne

con

cen

trat

ion

( n

g/m

l )

CigaretteGum 4 mg

Gum 2 mg

InhalerNasal sprayPatch

5 10 15 20 25 30 0

2

4

6

8

10

12

14

Plasma nicotine concentrations for smoking and NRT

Source: Balfour DJ & Fagerström KO. Pharmacol Ther 1996 72:51-81.

NRT with limitedbehavioural support

Intervention Effectsize

95% CI

Nicotine gum 5% 4%-6%Nicotine transdermal patch 5% 4%-7%

West R, McNeill A and Raw M. Thorax 2000; 55: 987-999. Silagy C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2002; 1.

NRT with intensive support

Intervention Effect size 95% CINicotine gum 8% 6%-10%Nicotine transdermal patch 6% 5%-8%Nicotine nasal spray 12% 7%-17%Nicotine inhalator 8% 4%-12%Nicotine sublingual tablet 8% 1%-14%

West R, McNeill A and Raw M. Thorax 2000; 55: 987-999. Silagy C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2002; 1.

The effectiveness of smoking cessation in primary care

Importance of primary care

0

5

10

15

20

No action

Brief advice

Brief advice

with NRT

Ces

sati

on

rat

es (

%)

Ces

sati

on

rat

es (

%)

Reproduced and adapted with kind permission of Gay Sutherland and John Stapleton of the Maudsley Hospital Smoking Cessation Clinic and the Institute of Psychiatry.

Conservative figures; absolute cessation rates, CO validated; not one puff; throughout one year

Intensive service

with NRT

Bupropion HCl SR acts on the neurotransmitters involved in

nicotine addictionModifies

dopaminereleasein ‘reward’ pathway

(mesolimbic system)

Alters noradrenergic

activityin ‘withdrawal’

pathway(locus coeruleus)

Pharmacotherapy

West R, McNeill A and Raw M. Thorax 2000; 55: 987-999. Hughes JR, et al. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2000; 4.

Bupropion

Bupropion is an effective aid to smoking cessation

Intervention Target population Effectsize

95% CI

Bupropion(300mg/day SR)

Moderate to heavysmokers receivingintensive behaviouralsupport

9% 5%-14%

Bupropion

• Limited evidence from a single trial that bupropion is more effective than nicotine patch alone, and that a combination of bupropion and the patch is more effective than nicotine patch alone.

Contraindications to bupropion HCl SR

• Hypersensitivity to bupropion / excipients

• Current/previous seizure or eating disorder

• Known CNS tumour

• Abrupt withdrawal from alcohol or benzodiazepines

• Severe hepatic cirrhosis

• Concomitant use with MAOIs

• History of bipolar disorder

Pharmacotherapy

White AR, et al. Acupuncture for smoking cessation. Cochrane Database Syst Rev 2002; 1. Abbot NC, et al. Hypnotherapy for smoking cessation. Cochrane Database Syst Rev 2002; 1. USDHHS. Treating Tobacco use and dependence. A clinical practice guideline. Rockville, MD: AHQR 2000.

Acupuncture and Hypnotherapy

• Acupuncture and hypnotherapy have not been shown to aid smoking cessation over and above any placebo effect

Cost effectiveness

Cost of saving one year of life

£0

£5,000

£10,000

£15,000

£20,000

Smoking cessation Typical intervention

Cost-effectiveness of smoking cessation

• Effect on other expenditures arising from the consequences of smoking

• 87% with heart attack risk over 3% (the risk threshold used in Sheffield tables) are smokers

• Stopping smoking would reduce the risk to below the threshold for statins prescribing for most patients

Cost effectiveness comparisons

• Smoking cessation < £1,000

• Statins £6,000-£13,000

• Benchmark £30,000?

NICE

• Acknowledged the cost-effectiveness of smoking cessation

• NRT and bupropion should be recommended for smokers who have expressed a desire to quit smoking

Assuming we meet our targets:

• Reduce smoking rates among manual groups from 32% (1998) to 26% (2010)

• This would still leave millions of smokers

• Highly likely that prevalence would not decrease uniformly and that smoking prevalence would remain very high in most deprived groups

Assuming we meet our targets:

• High prevalence among specific groups such as psychiatric populations, prison populations

• Health effects of active smoking, passive smoking effects, role models..

• Still not offering a less harmful alternative for those that cannot or will not stop

What would a harm reduction policy look like?

• Cigarette= dirty syringe

• Focus on less harmful ways of using nicotine

– make cigarettes less harmful

– broaden access to NRT products

– encouraging other forms of tobacco use which may be less harmful

– encouraging other less harmful forms of nicotine delivery

Controversies?

• Could it increase overall (population) harm?– If it dissuaded some smokers from quitting

– If it attracted non-smokers?

– If it encouraged ex-smokers to relapse

• But can we deny individuals the right to use a less harmful product?

Harm reduction approaches

• Low priority

• Main changes last century were introduction of filters & low tar cigarettes

• Danger - some have argued that consumption would be lower today if these products had not been introduced

Harm reduction approaches

• Smokers compensate to maintain their nicotine levels

• Tobacco industry exploited low tar by marketing as ‘light’, ‘mild’ etc

Harm reduction approaches

• Could cigarettes be made less harmful?

• Knowledge largely rests with tobacco industry

• Cigarette is highly technical engineered product

• But if effective, product modification would be beneficial to those who cannot stop (& improve inequalities) & could have beneficial internationally

Harm reduction approaches

• Happening anyway - tobacco industry introducing new nicotine delivery devices

• Smokeless tobacco - less harmful, but banned throughout EU except Sweden

Harm reduction approaches

• Least harmful, most beneficial products most stringently regulated

• Most toxic, lethal products (cigarettes) are hardly regulated at all

• Regulation is upside down

NRT Regulation Critiques

• McNeill A, Foulds J, Bates C (2001) Regulation of nicotine replacement therapies (NRT): a critique of current practice. Addiction, 96: 1757-68.

• McNeill A, Hendrie A (2001) Regulation of nicotine therapies: an expert consensus. WHO European Partnership Project, WHO Europe.

NRT Regulation Critiques

• Pregnancy advice

• Age restrictions

• Smokers with cardiovascular disease

• Use of NRT to reduce and control cigarette consumption– Use of NRT to support temporary abstinence

– Reducing smoke intake from tobacco by allowing concomitant NRT use and smoking

NRT Regulation Critiques

• Use for long-term maintenance

• NRT combinations

• Wider availability of NRT products

• Possibility of tobacco competitive nicotine delivery devices for recreational use

NRT Regulation Critiques

• Framework in which NRT is regulated:– does not properly weigh the risks and

benefits of NRT use in situations in which its use is qualified, restricted or contraindicated

– considers the risk of the medication but not the risks of failure to stop smoking

Current nicotine regulation

Treatment

LDCs Tobacco

Legal

Illegal

Long term nicotine regulation

Nicotine delivery

Legal

Illegal

HarmAbuse liabilityAddictivenessClaims & promotion